Substrate
Topic

car-t-therapy

2 stories related to this topic, newest first.

CREATE Medicines Raises $122 Million to Advance CAR-T Candidates Into Human Trialsrte.ie
health15 days agoDeveloping

CREATE Medicines Raises $122 Million to Advance CAR-T Candidates Into Human Trials

The biotechnology company, formerly known as Myeloid Therapeutics, secured the funding from Newpath Partners, ARCH Venture Partners and Hatteras Venture Partners. CREATE Medicines, cofounded by Siddhartha Mukherjee, is developing CAR-T therapies using myeloid cells to target soli…

Stat
1 source
Small Study Shows Modified Immune Cells Suppress HIV in Two PatientsThe Independent
world17 days agoDeveloping

Small Study Shows Modified Immune Cells Suppress HIV in Two Patients

Researchers reported that a single dose of genetically engineered CAR-T cells strongly suppressed HIV in two people for nearly one and two years without daily medication. The early-stage experiment modified immune cells to better target HIV-infected cells while protecting them fr…

The Independent
1 source